CRISPR THERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 11, 2018, a trademark application was filed for CRISPR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CRISPR THERAPEUTICS trademark a serial number of 87980024. The federal status of this trademark filing is REGISTERED as of Tuesday, November 19, 2019. This trademark is owned by CRISPR Therapeutics AG. The CRISPR THERAPEUTICS trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to i...
crispr therapeutics

General Information

Serial Number87980024
Word MarkCRISPR THERAPEUTICS
Filing DateWednesday, April 11, 2018
Status700 - REGISTERED
Status DateTuesday, November 19, 2019
Registration Number5916961
Registration DateTuesday, November 19, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesEducation services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Goods and ServicesScientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code041
First Use Anywhere DateThursday, October 31, 2013
First Use In Commerce DateThursday, October 31, 2013
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code042
First Use Anywhere DateThursday, October 31, 2013
First Use In Commerce DateThursday, October 31, 2013

Trademark Owner History

Party NameCRISPR Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressZUG V8 6300
CH
Party NameCRISPR Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events

Event DateEvent Description
Tuesday, August 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Tuesday, August 7, 2018NON-FINAL ACTION WRITTEN
Tuesday, August 7, 2018NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 7, 2019DIVISIONAL REQUEST RECEIVED
Thursday, February 7, 2019TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, February 12, 2019ASSIGNED TO LIE
Wednesday, February 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 21, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, March 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2019NON-FINAL ACTION WRITTEN
Wednesday, March 13, 2019NON-FINAL ACTION E-MAILED
Wednesday, September 25, 2019EXAMINER'S AMENDMENT ENTERED
Friday, April 26, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 26, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 25, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, September 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 1, 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, October 11, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 19, 2019REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, August 5, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 5, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 7, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 7, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 7, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, April 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 9, 2025TEAS SECTION 8 RECEIVED
Tuesday, November 19, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics crispr gene editing research modulation transcriptional scientific genome therapy services pharmaceuticals